A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma

Robert G. Fenton, Ronald G. Steis, Karen Madara, Arnold H. Zea, Augusto C. Ochoa, John Edward Janik, John W. Smith, Barry L. Gause, William H. Sharfman, Walter J. Urba, Michael G. Hanna, Robert L. DeJager, Mark X. Coyne, Robert D. Crouch, Pat Gray, Joy Beveridge, Stephen P. Creekmore, Jon Holmlund, Brendan D. Curti, Mario SznolDan L. Longo

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences